The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nasobec 50 Micrograms Aqueous Nasal Spray

Teva B.V.PA1986/055/001

Main Information

Trade NameNasobec 50 Micrograms Aqueous Nasal Spray
Active SubstancesBeclometasone dipropionate
Dosage FormNasal spray, suspension
Licence HolderTeva B.V.
Licence NumberPA1986/055/001

Group Information

ATC CodeR01AD Corticosteroids
R01AD01 beclometasone


License statusAuthorised
Licence Issued04/03/1999
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back